Natera EV/EBITDA Ratio 2011-2026 | NTRA

Annual EV/EBITDA Ratio Natera

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-19.5	-42.5	-20.6	-8.6	-5.32	-5.34	-4.37	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-4.37	-42.5	-15.2

EV/EBITDA Ratio of other stocks in the Diagnostics research industry

Issuer	EV/EBITDA Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	0.387	-	-6.23 %	$ 30.6 M	Germany
Anixa Biosciences ANIX	-2.25	$ 3.03	-2.26 %	$ 98.3 K	USA
Akumin AKU	28.1	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	-2.63	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	-26.9	-	-13.05 %	$ 7.29 M	USA
Brainsway Ltd. BWAY	-43.6	$ 23.35	-2.91 %	$ 99.4 M	Israel
Burning Rock Biotech Limited BNR	-1.51	$ 34.5	2.16 %	$ 371 M	China
Accelerate Diagnostics AXDX	-5.56	-	-61.36 %	$ 2.46 M	USA
BioNano Genomics BNGO	-7.71	$ 1.29	-12.26 %	$ 1.64 M	USA
Castle Biosciences CSTL	-21.2	$ 39.74	1.48 %	$ 1.1 B	USA
Check-Cap Ltd. CHEK	-0.674	-	-	$ 9.42 M	Israel
Oxford Immunotec Global PLC OXFD	-73.4	-	-	$ 562 M	Britain
Chembio Diagnostics CEMI	-1.23	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	3.62	-	-	$ 79.8 M	USA
Danaher Corporation DHR	20.1	$ 219.29	-0.08 %	$ 160 B	USA
Exact Sciences Corporation EXAS	-20.8	$ 102.41	0.1 %	$ 19 B	USA
Fulgent Genetics FLGT	2.58	$ 26.19	-0.19 %	$ 792 M	USA
DermTech DMTK	-2.44	-	-11.32 %	$ 2.94 M	USA
Global Cord Blood Corporation CO	-3.52	-	-	$ 399 M	China
Fluidigm Corporation FLDM	-13.6	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	-2.67	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-2.67	-	0.12 %	$ 80.1 M	China
Guardant Health GH	-28.8	$ 113.17	2.43 %	$ 13.9 B	USA
PRA Health Sciences, Inc. PRAH	20.8	-	-	$ 10.7 B	USA
DexCom DXCM	39.5	$ 73.31	-0.93 %	$ 28.3 B	USA
CareDx, Inc CDNA	-100	$ 20.55	-1.23 %	$ 1.1 B	USA
Celcuity CELC	-2.38	$ 109.48	-2.35 %	$ 4.32 B	USA
DarioHealth Corp. DRIO	-1.05	$ 10.2	-0.97 %	$ 289 M	Israel
Enzo Biochem ENZ	58.3	-	-8.98 %	$ 14.8 K	USA
Lantheus Holdings LNTH	-187	$ 66.91	0.34 %	$ 4.63 B	USA
Heska Corporation HSKA	141	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	-1.42	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	70.5	$ 144.81	-3.26 %	$ 23 B	USA
NeoGenomics NEO	-33.5	$ 11.99	-3.35 %	$ 1.52 B	USA
QIAGEN N.V. QGEN	13.2	-	-	$ 10.6 B	Niderland
IQVIA Holdings IQV	24.1	$ 230.33	-2.19 %	$ 41.8 B	USA
Charles River Laboratories International CRL	22	$ 210.51	-0.59 %	$ 10.8 B	USA
Personalis PSNL	-7.07	$ 9.33	-6.42 %	$ 553 M	USA
Medpace Holdings MEDP	30.7	$ 582.66	-1.76 %	$ 18 B	USA
Quest Diagnostics Incorporated DGX	5.51	$ 186.45	2.27 %	$ 20.7 B	USA
Biodesix BDSX	-4.25	$ 10.11	4.66 %	$ 1.31 B	USA
Motus GI Holdings MOTS	0.351	-	-34.28 %	$ 263 K	Israel
Precipio PRPO	-1.8	$ 24.07	-0.78 %	$ 31.2 M	USA
Laboratory Corporation of America Holdings LH	8.7	$ 271.34	0.56 %	$ 22.8 B	USA
Mettler-Toledo International MTD	827	$ 1 370.47	-1.61 %	$ 29.1 B	Schweiz
ICON Public Limited Company ICLR	38	$ 181.44	-2.39 %	$ 15 B	Irlanda
IDEXX Laboratories IDXX	45.3	$ 672.84	-0.57 %	$ 55.5 B	USA
Koninklijke Philips N.V. PHG	55.6	$ 28.66	-2.02 %	$ 20 B	Niderland
Agilent Technologies A	27.4	$ 133.33	0.07 %	$ 40.5 B	USA
Biomerica BMRA	-6.24	$ 2.41	0.84 %	$ 5.54 M	USA